Back

SGLT2 inhibitors in patients with amyloidosis and heart failure: a worldwide retrospective cohort study

31 August 2024 (10:20 - 10:30)
Organised by: Logo
Congress Presentation Part of: Daily cardiac problems in cancer patients Cardio-Oncology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Rafael Belo Nunes

Hospital Alemao Oswaldo Cruz, Sao Paulo (Brazil)

5 More presentations in this session

Presentation thumbnail
The initial high-dose versus maintenance-dose anticoagulation therapy with direct oral anticoagulants for cancer-associated venous thromboembolism: from the COMMAND VTE Registry-2
Doctor R. Chatani (Kurashiki, JP)
Abstract Slides Video
Presentation thumbnail
Understanding the impact of heart failure treatment on cancer growth
Miss C. Civati (Antwerp, BE)
Abstract Slides Video
Presentation thumbnail
Risk of cardiovascular disease in Hodgkin lymphoma patients
Doctor S. Godtfredsen (Aalborg, DK)
Abstract Slides Video
Presentation thumbnail
Prediction of cancer therapy related cardiac dysfunction by using a machine learning approach with cardiac magnetic resonance images
Doctor C. Yu (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Increased prevalence of coronary atherosclerosis in cancer survivors: a matched cross-sectional study with coronary CT angiography
Miss E. Polomski (Leiden, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Daily cardiac problems in cancer patients
Video

The Event

Event poster

ESC Congress 2024

31 August 2024 10:20 CET
You may be interested in
thumbnail
Congress Presentation
SGLT2 inhibitor treatment in patients with cardiac amyloidosis
thumbnail
Congress Presentation
SGLT2i on transthyretin amyloid cardiomyopathy - a new drug for an under-recognized cardiomyopathy
thumbnail
Congress Presentation
Treating heart failure in the context of amyloidosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources